(Q39732359)

English

Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

author name string

Chien-Liang Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Kang-Ju Chou

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Po-Tsang Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ying-Shou Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Tsu-Yuan Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chih-Yang Hsu

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wei-Chieh Huang

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Hsiao-Min Chung

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Hua-Chang Fang

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

2 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

316

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1109-1118

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

An overview of epithelio-mesenchymal transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial-mesenchymal transition and its implications for fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Evidence that fibroblasts derive from epithelium during tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

How cells read TGF-beta signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Regulation of Smad activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Identifiers

10.1016/J.YEXCR.2010.02.022

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39732359&oldid=2089196449"